Table of contents
Oral Sessions (Day1, Day2, Day3)
Poster Presentations (Day1, Day2, Day3)
Oral Sessions
- Day 2, June 23(Thu.) 10:00-10:20 Room B (409 and 410)
-
2B-O1-1000 PDF
Development of Biomarker of Microglial Activation by Using Mass Spectrometry
Microglial activation is known to cause diseases such as chronic pain. Currently, there is no biomarker of microglial activation that can be easily evaluated. We focused on 24S-hydroxycholesterol (24OHC) in blood as a novel biomarker of microglial activation. An analytical method of 24OHC by LC/MS/MS was developed and validated to investigate its potential as a biomarker of microglial activation in animal model or human.